Clues to immune function and oncogenesis provided by events that activate the cell cycle machinery in normal human T cells

Journal of Leukocyte Biology

Volumn 62, Issue 4, 1997, Pages 430-437

  Chitko McKown, Carol G ^a   Modiano, Jaime F ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Cyclin dependent kinases; Cyclins; Signal transduction; T lymphocytes

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; CYTOKINE; INTERLEUKIN 2;

CARCINOGENESIS; CELL CYCLE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0030828155     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.62.4.430     Document Type: Review

References (113)

1. Pardee, A. B. (1989) G1 events and the regulation of cell proliferation. Science 246, 603-608.
2. Weinberg, R. A. (1995) The molecular basis of oncogenes and tumor suppressor genes. Ann. NY Acad. Sci. 758, 331-338.
3. Lees, E. (1995) Cyclin dependent kinase regulation. Curr. Op. Cell Biol. 7, 773-780.
4. Morgan, D. O. (1995) Principles of CDK regulation. Nature 374, 131-134.
5. Sherr, C. J. (1994) G1 phase progression: cycling on cue. Cell 79, 551-555.
6. Sherr, C. J. (1996) Cancer cell cycles. Science 274, 1672-1677.
7. Elledge, S. J. (1996) Cell cycle checkpoints: preventing an identity crisis. Science 274, 1664-1672.
8. Kanellopoulos, J. M., De Petris, S., Leca, G., Crumpton, M. J. (1985) The mitogenic lectin from Phaseolus vulgaris does not recognize the T3 antigen of human T lymphocytes. Eur. J. Immunol. 15, 479-486.
9. Kern, J. A., Reed, J. C. Daniele, R. P., Nowell, P. C. (1986) The role of the accessory cell in mitogen-stimulated human T cell gene expression. J. Immunol. 137, 764-769.
10. Leca, G., Boumsell, L., Fabbi, M., Reinherz, E. L., Kanellopoulos, J. M. (1986) The sheep erythrocyte receptor and both alpha and beta chains of the human T-lymphocyte antigen receptor bind the mitogenic lectin (phytohaemagglutinin) from Phaseolus vulgaris. Scand. J. Immunol. 23, 535-544.
11. Modiano, J. F., Domenico, J., Szepesi, A., Terada, N., Lucas, J. J., Gelfand, E. W. (1995) Symmetry of the activation of cyclin-dependent kinases in mitogen and growth factor-stimulated T lymphocytes. Ann. NY Acad. Sci. 766, 134-148.
12. Schwinzer, R., Franklin, R. A., Domenico, J., Renz, H., Gelfand, E. W. (1992) Monoclonal antibodies directed to different epitopes in the CD3-TCR complex induce different states of competence in resting human T cells. J. Immunol. 148, 1322-1328.
13. Truneh, A., Albert, F., Golstein, P., Schmitt-Verhulst, A. M. (1985) Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature 313, 318-320.
14. Weiss, A., Shields, R., Newton, M., Manger, B., Imboden, J. (1987) Ligand-receptor interactions required for commitment to the activation of the interleukin 2 gene. J. Immunol. 138, 2169-2176.
15. Weiss, A., Imboden, J., Hardy, K., Stobo, J. (1987) The role of the antigen receptor/T3 complex in T-cell activation. Adv. Exp. Med. Biol. 213, 45-49.
16. Taichman, R. S., Torigoe, T. Tanaka, S., Miyashita, T., Reed, J. C. (1992) Gene transfer investigations of p56-LCK function in IL-2-dependent T-cell lines: implications for mechanisms of IL-2-signal transduction. Cytokine 4, 441-453.
17. Baker, P. E., Gillis, S., Smith, K. A. (1979) Monoclonal cytolytic T-cell lines. J. Exp. Med. 149, 273-278.
18. Hori, T., Uchiyama, T., Tsudo, M., Umadome, H., Ohno, H., Fukuhara, S., Kita, K., Uchino, H. (1987) Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus. Blood 70, 1069-1072.
19. Crabtree, G. R., Clipstone, N. A. (1994) Signal transmission between the plasma membrane and nucleus of T lymphoctytes. Annu. Rev. Biochem. 63, 1045-1083.
20. Weiss, A., Littman, D. R. (1994) Signal transduction by lymphocyte antigen receptors. Cell 76, 263-274.
21. Modiano, J. F., Domenico, J., Szepesi, A., Lucas, J. J., Gelfand, E. W. (1994) Differential requirements for interleukin-2 distinguish the expression and activity of the cyclin-dependent kinases Cdk4 and Cdk2 in human T cells. J. Biol. Chem. 269, 32972-32978.
22. Winston, J. T., Pledger, W. J. (1993) Growth factor regulation of cyclin D1 mRNA expression through protein synthesis-dependent and -independent mechanisms. Mol. Biol. Cell 4, 1133-1144.
23. Murray, A. W., Kirschner, M. W. (1989) Dominoes and clocks: the union of two views of the cell cycle. Science 246, 614-621.
24. Hartwell, L. H., Weinert, T. A. (1989) Check points: controls that ensure the order of cell cycle events. Science 246, 629-634.
25. Reed, S. I. (1992) The role of p34 kinases in the G1 to S-phase transition. Annu. Rev. Cell Biol. 8, 529-561.
26. Forsburg, S. L., Nurse, P. (1991) Cell cycle regulation in the yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe. Annu. Rev. Cell Biol. 7, 227-256.
27. Gautier, J., Minshull, J., Lohka, M., Glotzer, M., Hunt, T., Maller, J. L. (1990) Cyclin is a component of maturation-promoting factor from Xenopus. Cell 60, 487-494.
28. Lew, D. L., Dulic, V., Reed, S. I. (1991) Isolation of three human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell 66, 1197-1206.
29. Matsushime, H., Roussel, M. F., Sherr, C. J. (1991) Novel mammalian cyelins (CYL genes) expressed during G1. Cold Spring Harbor Symp. Quant. Biol. 56, 69-74.
30. Xiong, Y., Zhang, H., Beach, D. (1992) D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71, 505-514.
31. Hunter, T., Pines, J. (1994) Cyclins and cancer II: cyclin D and cdk inhibitors come of age. Cell 79, 573-582.
32. Sherr, C. J. (1993) Mammalian G1 cyclins. Cell 73, 1059-1065.
33. Sherr, C. J., Roberts, J. M. (1995) Inhibitors of mammalian cyclin-dependent kinases. Genes Dev. 9, 1149-1163.
34. Hunter, T. (1993) Braking the cycle. Cell 75, 839-841.
35. Matsuoka, M., Kato, J. Y., Fisher, R. P., Morgan, D. O., Sherr, C. J. (1994) Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol. Cell. Biol. 14, 7265-7275.
36. Tassan, J. P., Schultz, S. J., Bartek, J., Nigg, E. A. (1994) Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase). J. Cell Biol. 127, 467-478.
37. Fisher, R. P., Morgan, D. O. (1994) A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78, 713-724.
38. Leclerc, V., Tassan, J. P., O'Farrell, P. H., Nigg, E. A., Leopold, P. (1996) Drosophila Cdk8, a kinase partner of cyclin C that interacts with the large subunit of RNA polymerase II. Mol. Biol. Cell 7, 505-513.
39. Rickert, P., Seghezzi, W., Shanahan, F., Cho, H., Lees, E. (1996) Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II. Oncogene 12, 2631-2640.
40. Tassan, J. P. Jaquenoud, M., Leopold, P., Schultz, S. J., Nigg, E. A. (1995) Identification of human cyclin-dependent kinase 8, a putative protein kinase partner for cyclin C. Proc. Natl. Acad. Sci. USA 92, 8871-8875.
41. Reed, S. I., Wittenberg, C., Lew, D. J., Dulic, V., Henze, M. (1991) G1 control in yeast and animal cells. Cold Spring Harbor Symp. Quant. Biol. 56, 61-67.
42. Lees, E. M., Harlow, E. (1993) Sequences within the conserved cyclin box of human cyclin A are sufficient for binding to and activation of cdc2 kinase. Mol. Cell. Biol. 13, 1194.
43. Russo, A. A., Jeffrey, P. D., Patten, A. K., Massague, J., Pavletich, N. P. (1996) Crystal structure of the p27kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382, 325-331.
44. Meyerson, M., Faha, B., Su, L. K., Harlow, E., Tsai, L. H. (1991) The cyclin-dependent kinase family. Cold Spring Harbor Symp. Quant. Biol. 56, 177-186.
45. Meyerson, M., Harlow, E. (1994) Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14, 2077-2086.
46. Lucas, J. J., Szepesi, A., Modiano, J. F., Domenico, J., Gelfand, E. W. (1995) Identification and regulation of the PLSTIRE-protein (CDK6) as a major cyclin D-associated CDK4 homolog in normal human T lymphocytes. J. Immunol. 154, 6275-6284.
47. Lucas, J. J., Terada, N., Szepesi, A., Gelfand, E. W. (1992) Regulation of synthesis of p34cdc2 and its homologues and their relationship to p110Rb phosphorylation during cell cycle progression of normal human T cells. J. Immunol. 148, 1804-1811.
48. Lucas, J. J., Szepesi, A., Domenico, J., Tordai, A., Terada, N., Gelfand, E. W. (1995) Differential regulation of the synthesis and activity of the major cyclin-dependent kinases, p34cdc2, p33cdk2, and p34cdk4, during cell cycle entry and progression in normal human T lymphocytes. J. Cell. Physiol. 165, 406-416.
49. Szepesi, A., Gelfand, E. W., Lucas, J. J. (1994) Association of proliferating cell nuclear antigen with cyclin-dependent kinases and cyclins in normal and transformed human T lymphocytes. Blood 84, 3413-3421.
50. Martin-Castellanos, C., Moreno, S. (1997) Recent advances on cyclins, CDKs and CDK inhibitors. Trends Cell Biol. 7, 95-98.
51. Wollberg, P., Soderqvist, H., Nelson, B. D. (1994) Mitogen activation of human peripheral T lymphocytes induces the formation of new cyclic AMP response element-binding protein nuclear complexes. J. Biol. Chem. 269, 19719-19724.
52. Crabtree, G. R. (1989) Contingent genetic regulatory events in T lymphocyte activation. Science 243, 355-361.
53. Reed, J. C., Alpers, J. D., Nowell, P. C., Hoover, R. G. (1986) Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes. Proc. Natl. Acad. Sci. USA 83, 3982-3986.
54. Rooney, J. W., Sun, Y. L., Glimcher, L. H., Hoey, T. (1995) Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol. Cell. Biol. 15, 6299-6310.
55. Hoyos, B., Ballard, D. W., Bohnlein, E., Siekevitz, M., Greene, W. (1989) Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression. Science 244, 457-460.
56. Baeuerle, P. A., Baltimore, D. (1988) I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242, 540-546.
57. Durand, D. B., Bush, M. R., Morgan, J. G., Weiss, A., Crabtree, G. R. (1987) A 275 basepair fragment at the 5′ end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor. J. Exp. Med. 165, 395-407.
58. Lowenthal, J. W., Bohnlein, E., Ballard, D. W., Greene, W. C. (1988) Regulation of interleukin 2 receptor alpha subunit (Tac or CD25 antigen) gene expression: Binding of inducible nuclear proteins to discrete promoter sequences correlates with transcriptional activation. Proc. Natl. Acad. Sci. USA 85, 4468-4472.
59. Kato, J. Y., Matsuoka, M., Polyak, K., Massague, J., Sherr, C. J. (1994) Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kipl) of cyclin-dependent kinase 4 activation. Cell 79, 487-496.
60. Shiffman, D., Brooks, E. E., Brooks, A. R., Chan, C. S., Milner, P. G. (1996) Characterization of the human cyclin-dependent kinase 2 gene. Promoter analysis and gene structure. J. Biol. Chem. 271, 12199-12204.
61. Ishizuka, T., Ino, H., Sawa, K., Suzuki, N., Tatibana, M. (1995) Promoter region of the mouse cyclin-dependent kinase 5-encoding gene. Gene 166, 267-271.
62. Dulic, V., Lees, E., Reed, S. I. (1992) Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257, 1958-1961.
63. Koff, A., Giordano, A., Desai, D., Yamashita, K., Harper, J. W., Elledge, S., Nishimoto, T., Morgan, D. O., Franza, B. R., Roberts, J. M. (1992) Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257, 1689-1694.
64. Parker, L. L. (1992) Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science 257, 1955-1957.
65. Lorca, T., Labbe, J. C., Devault, A. (1992) Dephosphorylation of cdc2 on threonine 161 is required for cdc2 kinase inactivation and normal anaphase. Eur. Mol. Biol. Org. J. 11, 2381-2390.
66. Gu, Y. Rosenblatt, J., Morgan, D. O. (1992) Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. Eur. Mol. Biol. Org. J. 11, 3995-4005.
67. Gautier, J. (1991) cdc25 Is a specific tyrosine phosphatase that directly activates 34 cdc2. Cell 67, 197-211.
68. McGowan, C. H., Russell, P. (1993) Human Wee1 kinase inhibits cell division by phosphorylating p34(cdc2) exclusively on Tyr15. Eur. Mol. Biol. Org. J. 12, 75-85.
69. Watanabe, N., Broome, M., Hunter, T. (1995) Regulation of the human WEE1Hu Cdk tyrosine 15-kinase during the cell cycle. Eur. Mol. Biol. Org. J. 14, 1878-1891.
70. + encodes a protein phosphatase that dephosphorylates p34cdc2. Mol. Biol. Cell 3, 73-84.
71. Hoffmann, I., Draetta, G., Karsenti, E. (1994) Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition. Eur. Mol. Biol. Org. J. 13, 4302-4310.
72. Galaktionov, K., Jessus, C., Beach, D. (1995) Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation. Genes Dev. 9, 1046-1058.
73. Galaktionov, K., Lee, A. K., Eckstein, J., Draetta, G., Meckler, J., Loda, M., Beach, D. (1995) CDC25 phosphatases as potential human oncogenes. Science 269, 1575-1577.
74. Conklin, D. S., Galaktionov, K., Beach, D. (1995) 14-3-3 proteins associate with cdc25 phosphatases. Proc. Natl. Acad. Sci. USA 92, 7892-7896.
75. Shapiro, G. I., Edwards, C. D., Kobzik, L., Godleski, J., Richards, W., Sugarbaker, D. J., Rollins, B. J. (1995) Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res. 55, 505-509.
76. Yeager, T., Stadler, W., Belair, C., Puthenveettil, J., Olopade, O., Reznikoff, C. (1995) Increased p16 levels correlate with pRb alterations in human urothelial cells. Cancer Res. 55, 493-497.
77. Weinberg, R. A. (1997) The cat and mouse games that genes, viruses, and cells play. Cell 88, 573-575.
78. Zhang, W., Grasso, L., McClain, C. D., Gambel, A. M., Cha, Y., Travali, S., Deisseroth, A. B., Mercer, W. E. (1995) p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/marrophage differentiation. Cancer Res. 55, 668-674.
79. Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., Jacks, T. (1995) p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9, 935-944.
80. Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., Koff, A. (1994) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22.
81. Slingerland, J. M., Hengst, L., Pan, C. H., Alexander, D., Stampfer, M. R., Reed, S. I. (1994) A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol. Cell. Biol. 14, 3683-3694.
82. Nourse, J., Firpo, E., Flanagan, W. M., Coats, S., Polyak, K., Lee, M. H., Massague, J., Crabtree, G. R., Roberts, J. M. (1994) Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372, 570-573.
83. Fero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo, E., Polyak, K., Tsai, L. H., Broudy, V., Perlmutter, R. M., Kaushansky, K., Roberts, J. M. (1996) A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85, 733-744.
84. Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V. C., Hoffman, E. S., Ono, M., Khanam, D., Hayday, A. C., Frohman, L. A., Koff, A. (1996) Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85, 721-732.
85. Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D. Y. Nakayama, K. (1996) Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85, 707-720.
86. Ajchenbaum, E, Ando, K., DeCaprio, J. A., Griffin, J. D. (1993) Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes. J. Biol. Chem. 268, 4113-4119.
87. Lucas, J. J., Szepesi, A., Domenico, J., Takase, K., Tordai, A., Terada, N., Gelfand, E. W. (1995) Effects of iron-depletion on cell cycle progression in normal human T lymphocytes: selective inhibition of the appearance of the cyclin A-associated component of the p33cdk2 kinase. Blood 86, 2268-2280.
88. Weinberg, R. A. (1995) The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
89. Lee, W. H., Hollingsworth, J. R. E., Qian, Y. W., Chen, P. L., Hong, F., Lee, E. Y. H. P. (1991) RB protein as a cellular "corral" for growth-promoting proteins. Cold Spring Harbor Symp. Quant. Biol. 56, 211-217.
90. Weintraub, S. J., Prater, C. A., Dean, D. C. (1992) Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358, 259-261.
91. Chen, L. I., Nishinaka, T, Kwan, K., Kitabayashi, I., Yokoyama, K., Fu, Y. F., Grünwald, S., Chiu, R. (1994) The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator. Mol. Cell. Biol. 14, 4380-4389.
92. Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., Weinberg, R. A. (1992) Effects of an Rb mutation in the mouse. Nature 359, 295-300.
93. Mittnacht, S., Hinds, P. W., Dowdy, S. F., Weinberg, R. A. (1991) Modulation of retinoblastoma protein activity during the cell cycle. Cold Spring Harbor Symp. Quant. Biol. 56, 197-209.
94. Akiyama, T., Ohuchi, T., Sumida, S. (1992) Phosphorylation of the retinoblastoma protein by cdk2. Proc. Natl. Acad. Sci. USA 89, 7900-7904.
95. Lees, E., Faha, B., Dulic, V., Reed, S. I., Harlow, E. (1992) Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev. 6, 1874-1885.
96. Kato, J., Matsushime, H., Hiebert, S. W., Ewen, M. E., Sherr, C. J. (1993) Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7, 331-342.
97. Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J. Y., Hanks, S. K., Roussel, M. F., Sherr, C. J. (1992) Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 71, 323-334.
98. Ewen, M. E., Sluss, H. K., Whitehouse, L. L., Livingston, D. M. (1993) TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74, 1009-1020.
99. Hu, Q. J., Lees, J. A., Buchkovich, K. J., Harlow, E. (1992) The retinoblastoma protein physically associates with the human cdc2 kinase. Mol. Cell. Biol. 12, 971-980.
100. DeCaprio, J. A., Furukawa, Y., Ajchenbaum, F., Griffin, J. D., Livingston, D. M. (1992) The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc. Natl. Acad. Sci. USA 89, 1795-1798.
101. Furukawa, Y., DeCaprio, J. A., Freedman, A., Kanakura, Y., Nakamura, M., Ernst, T. J., Livingston, D. M., Griffin, J. D. (1990) Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells. Proc. Natl. Acad. Sci. USA 87, 2770-2774.
102. Terada, N., Lucas, J. J., Gelfand, E. W. (1991) Differential regulation of the tumor suppressor molecules, retinoblastoma susceptibility gene product (Rb) and p53, during cell cycle progression of normal human T cells. J. Immunol. 147, 698-704.
103. Wu, C. L., Zukerberg, L. R., Ngwu, C., Harlow, E., Lees, J. A. (1995) In vivo association of E2F and DP family proteins. Mol. Cell. Biol. 15, 2536-2546.
104. Moberg, K., Starz, M. A., Lees, J. A. (1996) E2F-4 switches from p130 to p107 and pRb in response to cell cycle reentry. Mol. Cell. Biol. 16, 1436-1449.
105. Wade, M., Blake, M. C., Jambou, R. C., Helin, K., Harlow, E., Azizkhan, J. C. (1995) An inverted repeat motif stabilizes binding of E2F and enhances transcription of the dihydrofolate reductase gene. J. Biol. Chem. 270, 9783-9791.
106. Helin, K., Wu, C. L., Fallacy, A. R., Lees, J. A., Dynlacht, B. D., Ngwu, C., Harlow, E. (1993) Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev. 7, 1850-1861.
107. Helin, K., Harlow, E. (1994) Heterodimerization of the transcription factors E2F-1 and DP-1 is required for binding to the adenovirus E4 (ORF6/7) protein. J. Virol. 68, 5027-5035.
108. Smith, E. J., Nevins, J. R. (1995) The Rb-related p107 protein can suppress E2F function independently of binding to cyclin A/cdk2. Mol. Cell. Biol. 15, 338-344.
109. Zhu, L., Van Den Heuvel, S., Helin, K., Fattaey, A., Ewen, M., Livingston, D., Dyson, N., Harlow, E. (1993) Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7, 1111-1125.
110. Blanchard, D. A., Affredou, M. T., Vazquez, A. (1997) Modulation of the p27(Kip1) cyclin-dependent kinase inhibitor expression during IL-4-mediated human B cell activation. J. Immunol. 158, 3054-3061.
111. Kobayashi, K., Phuchareon, J., Inada, K., Tomita, Y., Koizumi, T., Hatano, M., Miyatake, S., Tokuhisa, T. (1997) Overexpression of c-fos inhibits down-regulation of a cyclin-dependent kinase-2 inhibitor p27(Kip1) in splenic B cells activated by surface Ig cross-linking. J. Immunol. 158, 2050-2056.
112. Carman, J. A., Wechsler-Reya, R. J., Monroe, J. G. (1996) Immature stage B cells enter but do not progress beyond the early G1 phase of the cell cycle in response to antigen receptor signaling. J. Immunol. 156, 4562-4569.
113. Tanguay, D. A., Chiles, T. C. (1996) Regulation of the catalytic subunit (p34PSK-J3/cdk4) for the major D-type cyclin in mature B lymphocytes. J. Immunol. 156, 539-548.